HEALTH NOTES: Egg scientists crack hair loss
An egg a day may keep hair loss at bay, according to dermatologists in Japan. A series of studies, in which human hair follicles were implanted into mice, found that egg yolk stimulated growth.
Publication date: Available online 22 May 2019Source: Actas Dermo-Sifiliográficas (English Edition)Author(s): B. Monteagudo, S. Peña-López, D. Santos-García
Anogenital warts are caused by human papillomavirus types 6 and 11. They are rare in children, and treatment is difficult since conventional treatments are generally painful and require the patient to be anesthetized. Topical diphenylcyclopropenone (DPCP) is a contact immunotherapy used for treatments of recalcitrant warts and alopecia areata. We herein report 3 cases of anogenital warts in children successfully treated with topical DPCP. Our results suggest that topical DPCP may be a valuable option for the treatment of anogenital warts in children who have difficulty with painful destructive therapy.Case Rep Dermatol 2019;11:123 –129
Minoxidil, marketed under the brand name Regaine in the UK, works by helping the blood flow to hair follicles - the part of the skin which grows a hair by packing old cells together.
This article reviews the implementation of a cold cap program at a community breast health center. The results of the program indicate that patients who receive detailed education on scalp cooling with a cold cap, as well as have a trained cold capper to assist them with using the device, have an increased chance of limiting alopecia and retaining the majority of their hair. PMID: 31099802 [PubMed - in process]
This article is protected by copyright. All rights reserved. PMID: 31102412 [PubMed - as supplied by publisher]
Dasatinib (Bristol-Myers Squibb) is a short-acting inhibitor of multiple tyrosine kinases which is used orally in treatment of chronic myeloid leukemia, Philadelphia-chromosome positive acute Lymphoblastic leukemia (ALL), solid tumors and systemic mastocytosis . Despite acceptable safety profile of dasatinib, cutaneous adverse reactions including xerosis, keratosis pilaris, pruritus, maculopapular/exfoliative rashes, edema, alopecia may limit its use in crucial conditions . In case of drug-related cutaneous rashes, the primary approach is withdrawal of the culprit agent and introduction of supportive treatment.
;-Galván S PMID: 31109632 [PubMed - as supplied by publisher]
IJERPH, Vol. 16, Pages 1726: Finasteride-Induced Inhibition of 5α-Reductase Type 2 Could Lead to Kidney Damage—Animal, Experimental Study International Journal of Environmental Research and Public Health doi: 10.3390/ijerph16101726 Authors: Mirza Saim Baig Agnieszka Kolasa-Wołosiuk Anna Pilutin Krzysztof Safranow Irena Baranowska-Bosiacka Joanna Kabat-Koperska Barbara Wiszniewska In the pharmacological treatment of prostate cancer, benign prostatic hyperplasia and androgenetic alopecia finasteride is commonly used. This drug inhibits 5α-reductase type 2, which is why finasteride a...
AbstractAzole antifungals are first-line options in the prophylaxis and treatment of invasive fungal infections. They are often used for prolonged (weeks to months) periods of time, particularly in patients with hematologic malignancies, or in those who have received a solid organ or hematopoietic stem cell transplant. Long-term use of azoles is associated with hepatotoxicity and hormone-related effects, including gynecomastia, alopecia, decreased libido, oligospermia, azoospermia, impotence, hypokalemia, hyponatremia, and (rarely) adrenal insufficiency. Voriconazole and posaconazole have been associated with peripheral ne...
Authors: Rodríguez-Cerdeira C, Muñoz-Garzón V, González-Cespón JL Abstract No effective therapy exists for locally advanced or metastatic basal cell carcinoma (BCC). Vismodegib is a small molecule that is an inhibitor of the hedgehog pathway. An oral treatment to inactivate Smoothened would be a new therapeutic approach to treat advanced BCC. We studied two patients with advanced BCC and analysed variables, including age and sex of the patient, tumour location and size, time of evolution and nature of the tumour (primary or recurrent), type of treatment, route of administration, t...